Chronic hepatitis B Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus, Antimicrob. Agents Chemother, vol.43, pp.190-193, 1999. ,
Lack of an Effect of Human Immunodeficiency Virus Coinfection on the Pharmacokinetics of Entecavir in Hepatitis B Virus-Infected Patients, Antimicrobial Agents and Chemotherapy, vol.52, issue.8, pp.2836-2841, 2008. ,
DOI : 10.1128/AAC.01366-07
How to address the sample preparation of hydrophilic compounds: Determination of entecavir in plasma and plasma ultrafiltrate with novel extraction sorbents, LC-ESI-MS/MS method for the quantification of entecavir in human plasma and its application to bioequivalence study, pp.377-344, 2014. ,
DOI : 10.1016/j.jpba.2013.08.034
A sensitive method for the determination of entecavir at picogram per milliliter level in human plasma by solid phase extraction and high-pH LC???MS/MS, Journal of Pharmaceutical and Biomedical Analysis, vol.49, issue.4, pp.49-1027, 2009. ,
DOI : 10.1016/j.jpba.2009.02.003
Highly sensitive fast determination of entecavir in rat urine by means of hydrophilic interaction chromatography???ultra-high-performance liquid chromatography???tandem mass spectrometry, Journal of Chromatography A, vol.1259 ,
DOI : 10.1016/j.chroma.2012.03.078
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence, Medical Care, vol.24, issue.1, pp.67-74, 1986. ,
DOI : 10.1097/00005650-198601000-00007
Determination of Entecavir in Human Plasma using LC, MS/MS, Sci. Discip. Sci. Ingenuity. Web Www.tandemlabs.com, 2014. ,
European Association for the Study of the Liver, EASL Clinical Practice Guidelines: Management of chronic hepatitis B, J. Hepatol, vol.50, issue.1, pp.227-242, 2009. ,
Estimation of tenofovir's population pharmacokinetic parameters without reliable dosing histories and application to tracing dosing history using simulation strategies, The Journal of Clinical Pharmacology, vol.35, issue.4, pp.54-150, 2014. ,
DOI : 10.1002/jcph.221
Pharmacokinetics and food interaction of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy volunteers, Journal of Clinical Pharmacy and Therapeutics, vol.37, issue.2, pp.136-140, 2013. ,
DOI : 10.1111/jcpt.12023
Clinical and virologic response to entecavir in HBV related chronic hepatitis or cirrhosis: data from the clinical practice in a single centre cohort, Antiviral Therapy, vol.18, issue.1, pp.87-94, 2013. ,
DOI : 10.3851/IMP2284
Lack of an Effect of Human Immunodeficiency Virus Coinfection on the Pharmacokinetics of Entecavir in Hepatitis B Virus-Infected Patients, Antimicrobial Agents and Chemotherapy, vol.52, issue.8, pp.2836-2841, 2008. ,
DOI : 10.1128/AAC.01366-07
Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds, Journal of Chromatography A, vol.499, pp.499-177, 1990. ,
DOI : 10.1016/S0021-9673(00)96972-3
Théorie et instrumentation des techniques de LC-MS et LC-MS / MS applicables à la toxicologie LC-MS and LC-MS / MS theory and instruments applicable to toxicology, Ann. Toxicol. Anal. XVII, p.1, 2005. ,
Fréquence et signification des blips au cours du traitement de l'hépatite B par analogues de deuxième génération, Thèse de doctorat en médecine, 2014. ,